Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 13;23(1):477.
doi: 10.1186/s12889-023-15321-7.

Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review

Witchakorn Ruamtawee  1 , Mathuros Tipayamongkholgul  2 , Natnaree Aimyong  1 , Weerawat Manosuthi  3
Affiliations

Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review

Witchakorn Ruamtawee et al. BMC Public Health. .

Abstract

Background: Cardiovascular diseases (CVD) due to atherosclerosis have become one of the major causes of death among people living with HIV (PLHIV) since effective antiretroviral therapy (ART) has been available throughout the world. However, the epidemiologic evidence of this problem from the Asia-Pacific region remains unclear. We conducted a systematic review of the situation and risk factors for CVD among PLHIV in countries with the greatest impact of CVD attributable to HIV in the Asia-Pacific region.

Methods: A systematic search in PubMed/MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews databases for articles published before 2019 was conducted. Publications reported situations and risk factors both traditional and HIV-specific for CVD among PLHIV in the region were included. Two reviewers working on duplicate and quality assessments, independently extracted data, and thematically analyzed the data.

Results: Among PLHIV, the prevalence of subclinical CVD ranged from 10 to 28% and the incidence rate of clinical CVD ranged from 0.37 to 1.17 /100 person-years. Clinical CVD was frequently observed in the early era of the highly active antiretroviral therapy. A higher prevalence of subclinical CVD such as abnormal cIMT and carotid plaques was frequently observed in the PLHIV rather than in the nonHIV population and a high proportion of early onset of CVD was found among young PLHIV adults. The traditional risk factors for CVD such as hypertension, diabetes and smoking behavior were prevalent in both PLHIV and nonHIV populations ranging from 5 to 45%. HIV-specific risk factor, and lower CD4 presented almost twice the significantly increased risks for CVD while the synergistic interaction among traditional risk factors, i.e., diabetes mellitus, dyslipidemia and family history steeply increased the risk for CVD among PLHIV by almost 20 times.

Conclusion: The limited existing data suggested the risk of early CVD among PLHIV. We identified the crucial gaps in HIV/CVD work from the Asia-Pacific region and recommended longer prospective studies with larger sample sizes or meta-analyses to better capture CVD risk and interactions of crucial risk factors of this vulnerable population in this region.

Registration number: INPLASY202290108 ( https://inplasy.com/inplasy-2022-9-0108/ ).

Keywords: Asia; Cardiovascular diseases; HIV; Risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no completing interests.

Figures

Fig. 1
Fig. 1
PRISMA Flow Diagram for Selection Eligible Study
See this image and copyright information in PMC

References

    1. Burgoyne RW, Tan DHS. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act. J Antimicrob Chemother. 2008;61(3):469–73. doi: 10.1093/jac/dkm499. - DOI - PubMed
    1. Liao C, Yang C, Chen P, Ou H, Toh HS, Chen Z, Ko N. Direct medical costs associated with cardiovascular diseases among the HIV-infected patients in Taiwan: a population-based study. Value in Health. 2018 doi: 10.1016/j.jval.2018.07.026. - DOI
    1. Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People living with HIV. Circulation. 2018;138(11):1100–12. doi: 10.1161/CIRCULATIONAHA.117.033369. - DOI - PMC - PubMed
    1. Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–8. doi: 10.1016/S1473-3099(15)00056-0. - DOI - PMC - PubMed
    1. Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated atherosclerosis: unraveling the Missing Link. J Am Coll Cardiol. 2017;69(25):3084–98. doi: 10.1016/j.jacc.2017.05.012. - DOI - PMC - PubMed

Publication types